Evidera’s Chief Scientist, Dr. J. Jaime Caro, will be instructing EPIB 654 – Pharmacoeconomics for Health Technology Assessment at McGill University from May 27-30. This course focuses on the key concepts of assessing the reasonable price to pay for a pharmaceuticals’ given benefit and the development of models, such as the DICE simulation, to analyze costs and effectiveness and deal with all levels of uncertainty. For more information on course registration, please visit the McGill University course website by clicking the below link.
